Actively Recruiting

Age: 18Years +
FEMALE
ID07243587

Cohort of the Franco-European Multidisciplinary Institute of Endometriosis

Led by Clinique Tivoli Ducos · Updated on 2025-11-24

15000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Endometriosis is a chronic, non-cancerous gynecological condition that affects 5 to 10% of women of reproductive age and is often linked to pelvic pain, digestive issues, and infertility. This research aims to evaluate the long-term effects of various medical and surgical treatments for deep pelvic endometriosis on symptoms, quality of life, recurrence, and fertility outcomes. It is a prospective, observational, single-center study conducted at the Endometriosis Center of Clinique Tivoli-Ducos in Bordeaux, France. Participants include women with confirmed pelvic endometriosis diagnosed histologically or by imaging. Data is collected through standardized questionnaires completed at the start of the study and then again at 1, 3, 5, 7, and 10 years. The questionnaires cover symptoms, fertility status, and quality of life. Surgical details and complications are also recorded when surgery occurs. Data can be submitted via a secure online platform or paper forms. During the study, participants will complete follow-up questionnaires over a 10-year period. Researchers will monitor symptom changes, digestive function, fertility outcomes, disease progression, and treatment effectiveness. A quality assurance plan ensures data accuracy and completeness. The study aims to improve understanding of endometriosis' natural history and long-term treatment results to enhance patient care.

CONDITIONS

Brief Title

Cohort of the Franco-European Multidisciplinary Institute of Endometriosis

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged over 18 years
  • Women with histologically or radiologically confirmed deep endometriosis and/or infiltrating the colon and/or rectum
  • Women affiliated with the social security system
Not Eligible

You will not qualify if you...

  • Refusal to participate
  • Patients under guardianship or curatorship, or deprived of liberty

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Up to 1 week

Participants undergo confirmation of pelvic endometriosis diagnosis through histological or radiological methods.

1 visit (in-person)

Long-term Monitoring

Duration - 10 years

Participants complete questionnaires at inclusion and at 1, 3, 5, 7, and 10 years to evaluate symptoms, quality of life, fertility, and treatment outcomes.

6 questionnaire completions (baseline and 5 follow-up timepoints)

Trial Site Locations

Total: 1 location

1

Clinique Tivoli Ducos

Bordeaux, France, 33000

Actively Recruiting

Loading map...

Research Team

H

Horace ROMAN

C

Clotilde HUET

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Phase 2, Randomized, Double-blind, Placebo-controlled Tria...

Endometriosis

Actively Recruiting

41 locations

A Phase 3B, Single-Arm Study to Evaluate Bone Mineral Densit...

Uterine Fibroids

Actively Recruiting

120 locations

A Randomized Controlled Trial of a Nutritional Intervention ...

Endometriosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here